Direct Acting Antiviral
Showing 1 - 25 of >10,000
Diabetes, Hepatitis C, Chronic, Cardiovascular Diseases Trial run by the National Institute of Diabetes and Digestive and Kidney
Recruiting
- Diabetes Mellitus
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 27, 2023
Treatment of Hepatitis c by Using Direct-acting Antiviral
Not yet recruiting
- Hepatitis C
- Direct Acting Antivirals
- (no location specified)
May 9, 2022
Liver Cancer Trial in Houston (Bevacizumab, Atezolizumab, Sofosbuvir)
Not yet recruiting
- Liver Cancer
- Bevacizumab
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Feb 9, 2023
HCV Coinfection, Liver Disease, HIV Trial in Baltimore (Sofosbuvir/Velpatasvir/Voxilaprevir [SOF/VEL/VOX],
Completed
- HCV Coinfection
- +2 more
- Sofosbuvir/Velpatasvir/Voxilaprevir [SOF/VEL/VOX]
- Sofosbuvir/Velpatasvir (SOF/VEL)
-
Baltimore, MarylandJohns Hopkins Hospital : The John G. Bartlett Specialty Practice
Feb 10, 2022
Direct-acting Antiviral Drugs in Treatment of Hepatitis C in
Completed
- Inflammatory Bowel Diseases
- Hepatitis C Virus Infection
- Assess the effectiveness and safety of DAAs in patients with IBD.
- +2 more
-
Terrassa, Barcelona, SpainHospital Universitari Mutua Terrassa
Jul 8, 2022
Patterns of Liver Diseases Related Admissions After Era of DAAS
Not yet recruiting
- Patternsof Liver Diseasesadmissions After Era of DAAS
- liver diseases admissions
- (no location specified)
Mar 10, 2022
Direct-acting Antiviral Agents on HCV Cognitive Function, and
Recruiting
- Depression in Chronic Hepatitis C
- Depression and Cognitive Tests
-
Chandigarh, IndiaPostgraduate Institute of Medical Education and Research
Sep 26, 2021
Chronic Hepatitis c Trial in Assiut (lipid profile, fasting insulin, fibro scan)
Recruiting
- Chronic Hepatitis c
- lipid profile
- +2 more
-
Assiut, EgyptAssiut University hospital
Feb 23, 2022
Effect of DAAs on Behavior of HCC in HCV Patients
Completed
- Carcinoma, Hepatocellular
- Hepatitis C
-
Cairo, Egypt
- +2 more
Jul 19, 2021
Hepatitis C Trial in Tanta (Sofosbuvir and Daklatasuvir)
Recruiting
- Hepatitis C
- Sofosbuvir and Daklatasuvir
-
Tanta, EgyptSherief Abd-Elsalam
Oct 20, 2020
Follow up of IFN Vs DAAs HCV SVR (IFDACS Study)
Recruiting
- Chronic Hepatitis C Infection
-
Beijing, Beijing, China
- +2 more
Aug 27, 2021
Kidney Failure, Hepatitis C, Kidney Disease, Chronic Trial in Boston (Glecaprevir and Pibrentasvir)
Recruiting
- Kidney Failure
- +2 more
- Glecaprevir and Pibrentasvir
-
Boston, MassachusettsMassachusetts General Hospital
Jun 4, 2021
Hepatitis C Virus Infection Trial in Worldwide (Sofosbuvir (SOF), Ledipasvir/Sofosbuvir (LDV/SOF), Sofosbuvir/Velpatasvir
Terminated
- Hepatitis C Virus Infection
- Sofosbuvir (SOF)
- +3 more
-
Phoenix, Arizona
- +50 more
Jan 25, 2023
Chronic Hepatitis C Infection Trial in Beijing, Hong Kong (PR4 + LDV/SOF + ASV 4 wk, PR4 + LDV/SOF + SMV 4 wk, PR4 + LDV/SOF +
Recruiting
- Chronic Hepatitis C Infection
- PR4 + LDV/SOF + ASV 4 wk
- +7 more
-
Beijing, Beijing, China
- +1 more
Aug 27, 2021
Kidney Failure, Hepatitis C Trial (Direct Acting Antivirals)
Withdrawn
- Kidney Failure
- Hepatitis C
- Direct Acting Antivirals
- (no location specified)
Aug 12, 2020
Hepatitis C Trial (Zinc Supplement)
Not yet recruiting
- Hepatitis C
- Zinc Supplement
- (no location specified)
Jul 16, 2022
Direct Acting Antiviral Drugs
Completed
- Drug-Induced Liver Injury
- Flow cytometry and Western Blot analysis
-
Assiut, EgyptAssiut University
Apr 7, 2020
Quality of Life in HCV Related Liver Cirrhosis Before and After
Unknown status
- HCV Related Liver Cirrhosis Direct Acting Antiviral Drugs
- short form 36
- (no location specified)
Feb 9, 2020
Macrophages, Portal Hypertension, and Liver Function During
Completed
- Hepatitis C
- Functional Hepatic Nitrogen Clearance (FHNC)
- +2 more
-
Aarhus, DenmarkDepartment of Hepatology and Gastroenterology, Aarhus University
Nov 3, 2020
Hepatocellular Carcinoma Developed After Direct Acting Antiviral
Unknown status
- Hepatocellular Carcinoma
- DNA methylation
- (no location specified)
Jan 12, 2020
Resistance to AbbVie's 2 Direct-acting Antiviral Agent Therapy
Completed
- Hepatitis C Virus
-
Nagoya-shi, Aichi, Japan
- +52 more
Dec 6, 2021
Direct Acting Antiviral-Post Authorization Safety Study
Completed
- Hepatitis C
- Hepatocellular Carcinoma
-
Phoenix, Arizona
- +61 more
Jul 1, 2021
HCV RAS Testing in Public Health Programs
Unknown status
- Hepatitis C
- +3 more
- Direct Acting Antivirals
-
Chandigarh, India
- +1 more
Jan 22, 2020
The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry
Recruiting
- Hepatitis C
- Direct Acting Antivirals
-
Atlanta, GeorgiaThe Taskforce for Global Health
May 6, 2022
Long Term Follow up of Chronic HCV Patients Receiving DAAS
Recruiting
- Chronic Hepatitis c
-
Sohag, EgyptSohag University Hospital
Jun 29, 2022